Your browser doesn't support javascript.
loading
T2 Protect AD: Achieving a rapid recruitment timeline in a multisite clinical trial for individuals with mild to moderate Alzheimer's disease.
Shadyab, Aladdin H; LaCroix, Andrea Z; Matthews, Genevieve; Bennett, Daniel; Shadyab, Alexandre A; Tan, Donna; Thomas, Ronald G; Mason, Jennifer; Lopez, Alex; Askew, Brianna; Donahue, Lia; Kaplita, Stephen; Qureshi, Irfan A; Huisa, Branko; Feldman, Howard H.
Afiliación
  • Shadyab AH; Herbert Wertheim School of Public Health and Human Longevity Science University of California, San Diego La Jolla California USA.
  • LaCroix AZ; Alzheimer's Disease Cooperative Study University of California, San Diego La Jolla California USA.
  • Matthews G; Herbert Wertheim School of Public Health and Human Longevity Science University of California, San Diego La Jolla California USA.
  • Bennett D; Alzheimer's Disease Cooperative Study University of California, San Diego La Jolla California USA.
  • Shadyab AA; Alzheimer's Disease Cooperative Study University of California, San Diego La Jolla California USA.
  • Tan D; Alzheimer's Disease Cooperative Study University of California, San Diego La Jolla California USA.
  • Thomas RG; Alzheimer's Disease Cooperative Study University of California, San Diego La Jolla California USA.
  • Mason J; Alzheimer's Disease Cooperative Study University of California, San Diego La Jolla California USA.
  • Lopez A; Herbert Wertheim School of Public Health and Human Longevity Science University of California, San Diego La Jolla California USA.
  • Askew B; Alzheimer's Disease Cooperative Study University of California, San Diego La Jolla California USA.
  • Donahue L; Alzheimer's Disease Cooperative Study University of California, San Diego La Jolla California USA.
  • Kaplita S; Alzheimer's Disease Cooperative Study University of California, San Diego La Jolla California USA.
  • Qureshi IA; Alzheimer's Disease Cooperative Study University of California, San Diego La Jolla California USA.
  • Huisa B; Biohaven Pharmaceuticals, Inc. New Haven Connecticut USA.
  • Feldman HH; Biohaven Pharmaceuticals, Inc. New Haven Connecticut USA.
Alzheimers Dement (N Y) ; 8(1): e12265, 2022.
Article en En | MEDLINE | ID: mdl-35310528
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Alzheimers Dement (N Y) Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Alzheimers Dement (N Y) Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos